Erlotinib hydrochloride (Q43955796)

28 November 2017

Erlotinib hydrochloride (English)

1 reference

28 November 2017

Jonathan Dowell

1

1 reference

PubMed ID

15690599

28 November 2017

John D Minna

series ordinal

2

1 reference

PubMed ID

15690599

28 November 2017

Peter Kirkpatrick

series ordinal

3

1 reference

28 November 2017

1 January 2005

1 reference

Nature Reviews Drug Discovery

28 November 2017

1 reference

28 November 2017

4

1 reference

28 November 2017

1

1 reference

28 November 2017

13-14

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd1612

28 November 2017

0 references

cites work

Cancer burden in the year 2000. The global picture

1 reference

Issues and progress with protein kinase inhibitors for cancer treatment

21 January 2018

1 reference

Untangling the ErbB signalling network

21 January 2018

1 reference

Epidermal growth factor-related peptides and their receptors in human malignancies

21 January 2018

1 reference

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

21 January 2018

1 reference

Why the epidermal growth factor receptor? The rationale for cancer therapy

21 January 2018

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRD1612

1 reference

28 November 2017

1 reference